May 7, 2018 / 11:30 AM / in a year

FDA approves Kindred treatment for problem weight loss in cats

(Reuters) - Kindred Biosciences Inc has received the first U.S. approval for a treatment for unintended weight loss in cats, opening the door to a market it says extends to up to 9 million potential cases in the United States alone.

Miratazm, which helps cats gain weight, combats the potentially fatal disease and is applied to the cat’s inner ear once a day, avoiding what can be difficult oral treatment.

“Based on our market research, we estimate that veterinarians in the U.S. see as many as 9 million cats each year with unintended weight loss due to various underlying conditions,” Chief Executive Officer Richard Chin said in a statement.

Trading of shares in the company were halted in premarket trade.

Reporting by Tamara Mathias in Bengaluru; Editing by Maju Samuel and Patrick Graham

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below